Blood neutrophil subset predicts the success of immune checkpoint inhibitors in cancer

IF 67.7 1区医学 Q1 IMMUNOLOGY

Nature Reviews Immunology Pub Date : 2024-01-15 DOI:10.1038/s41577-024-00993-y

Yvonne Bordon

引用次数: 0

Abstract

A population of interferon-stimulated neutrophils can predict the success of immunotherapy outcomes in various cancers.

Abstract Image

查看原文本刊更多论文

血液中性粒细胞亚群可预测免疫检查点抑制剂治疗癌症的成功率

干扰素刺激的中性粒细胞群可以预测各种癌症的免疫疗法是否成功。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Immunology 医学-免疫学

CiteScore

93.40

自引率

0.40%

发文量

131

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Immunology is a journal that provides comprehensive coverage of all areas of immunology, including fundamental mechanisms and applied aspects. It has two international standard serial numbers (ISSN): 1474-1733 for print and 1474-1741 for online. In addition to review articles, the journal also features recent developments and new primary papers in the field, as well as reflections on influential people, papers, and events in the development of immunology. The subjects covered by Nature Reviews Immunology include allergy and asthma, autoimmunity, antigen processing and presentation, apoptosis and cell death, chemokines and chemokine receptors, cytokines and cytokine receptors, development and function of cells of the immune system, haematopoiesis, infection and immunity, immunotherapy, innate immunity, mucosal immunology and the microbiota, regulation of the immune response, signalling in the immune system, transplantation, tumour immunology and immunotherapy, and vaccine development.

文献相关原料

公司名称	产品信息	采购帮参考价格